Pasithea Therapeutics
(NASDAQ:KTTA)
$1.25
At close: Oct 4
$1.25
PreMarket: 4:05PM EDT
Day Range- - -52 Wk Range0.81 - 1.83Open / Close- / -Float / Outstanding24.5M / 26.7M
Vol / Avg.- / 488.4KMkt Cap33.4MP/E-50d Avg. Price1.21
Div / Yield-Payout Ratio-Total Float24.5MEPS-0.11

Pasithea Therapeutics Stock (NASDAQ:KTTA), Quotes and News Summary

Pasithea Therapeutics Stock (NASDAQ: KTTA)

Day Range- - -52 Wk Range0.81 - 1.83Open / Close- / -Float / Outstanding24.5M / 26.7M
Vol / Avg.- / 488.4KMkt Cap33.4MP/E-50d Avg. Price1.21
Div / Yield-Payout Ratio-Total Float24.5MEPS-0.11
Sector: Health Care.Industry: Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-17
REV
Q2 2022Est.ActualSurprise
EPS-0.110
REV13.581M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Pasithea Therapeutics Questions & Answers

Q
How do I buy Pasithea Therapeutics (KTTA) stock?
A

You can purchase shares of Pasithea Therapeutics (NASDAQ: KTTA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Pasithea Therapeutics's (KTTA) competitors?
Q
What is the target price for Pasithea Therapeutics (KTTA) stock?
A

The latest price target for Pasithea Therapeutics (NASDAQ: KTTA) was reported by EF Hutton on Tuesday, December 14, 2021. The analyst firm set a price target for 3.25 expecting KTTA to rise to within 12 months (a possible 160.00% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Pasithea Therapeutics (KTTA)?
A

The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $1.25 last updated October 4, 2022, 8:00 PM UTC.

Q
Does Pasithea Therapeutics (KTTA) pay a dividend?
A

There are no upcoming dividends for Pasithea Therapeutics.

Q
When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?
A

Pasithea Therapeutics’s Q3 earnings are confirmed for Thursday, November 17, 2022.

Q
Is Pasithea Therapeutics (KTTA) going to split?
A

There is no upcoming split for Pasithea Therapeutics.

Q
What sector and industry does Pasithea Therapeutics (KTTA) operate in?
A

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.